| Tag | Content |
|---|
EnhancerAtlas ID | HS187-10944 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr17:73319220-73320080 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MYC | MA0147.3 | chr17:73319750-73319762 | GAGCACGTGGCT | - | 6.04 |
|
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_09177 | chr17:73302035-73320268 | CD14 | | SE_10509 | chr17:73319249-73320057 | CD19_Primary | | SE_14041 | chr17:73319343-73320076 | CD34_Primary_RO01536 | | SE_25706 | chr17:73318350-73320087 | DND41 | | SE_54131 | chr17:73319199-73319933 | Spleen | | SE_61022 | chr17:73284104-73345918 | HBL1 | | SE_62513 | chr17:73287335-73369120 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I075322 | chr17 | 73318761 | 73320159 |
|
Enhancer Sequence | AAAGGCATTC TCTGAGAGTG CTTGTTCAAT GAATGAATGA GTCCCTCCTC TCCTTCAGTC 60
TTTCAGCTGA TGGAAACCAA AGGCTTCAGA AAATCAATCC GGCAGGTGGC AGCACTGAGC 120
CTCAAGGAAG CCACTCAGCA CAAGATGCCT CGCATTTGGA AAAAATACTG CTTTACATGT 180
TAAGACAAAA TGTGGAAGGT GAGAAAGCTT CATTAGCAAG GGTATATTCC ACGGCACTTC 240
TGGCCCCACA GAGGCCCACT TCCACCCATG CAATGCAGGT GGTTTCTAAG AGCCCAGGGC 300
CCCAATAATG AGCAGTGTTT CAAATCACAG GCTCAAAACA TCCTAAAACT AAGAAACATC 360
TGACAACTGT TGATTCTTGA ACCTTTTTTG CAGAGGTGTG TGTGTTGTTA AAGAGAGTCA 420
TGACACCTGC TTTGCTTCTA AAACAATAAA TGCATTAAAT CCTTAAAAGA TTCTACTTGA 480
GAAAATGGAA GTTTGAGAGT TTCTGCTGAG CAAACAGGCA GCGTCCAGCC GAGCACGTGG 540
CTGCCCCCGT GGTTTTGGCC ACCACCCAGT GATTTACTGC TTGTTCCCCT CATCTTATAA 600
GGTTTCAGTT ACACTTGGGT CAGTATAAAA CTAAAGAAAG ACAGGTGTCA CACATGTTTT 660
TCTTTTCTTT TTTTTTTTTT TTTAAAGATG GATGGAGTCT TGCTCTTTCA CCCAGGCTGG 720
AATGCAATGG CTCAGTCTCG GCTCACTGCA ACCTCTGCCT CCTAGGTTCA AGTGATTCTC 780
CTGCTTCAGC CTCCGGAGTA GCTGGGAATA CAGGCATGTG CCACCACGCC TGGCTAATTT 840
TTGTATTTTT TTAGTAGGGA 860
|
